Bristol-Myers Squibb Company (0R1F)
LSE
Closed
Aug 25, 2026
Day's Range
66.4252 wk Range
42.54Overview - 0R1F - Bristol-Myers Squibb Company
Key Statistics
Valuation
Enterprise Value
149.31B
P/E (Trailing)
‪18.09‬
PEG Ratio
‪0.11‬
Price / Sales (TTM)
‪3.19‬
Price / Book
‪4.38‬
EV / EBITDA
‪7.98‬
Profitability
Gross Margin
‪71.27%‬
Profit Margin
‪17.62%‬
Operating Margin
‪19.25%‬
Return on Assets
‪5.61%‬
Return on Equity
‪24.66%‬
Ownership
Shares Outstanding
2.04B
Float
2.08B
Held by Insiders
‪0.07%‬
Held by Institutions
‪78.20%‬
Price stats
Beta
‪0.34‬
50-Day Avg
‪60.34‬
200-Day Avg
‪57.45‬
Dividends
Payout Ratio
‪59.84%‬
Frequency
Quarterly
Market Cap - 0R1F - Bristol-Myers Squibb Company
Peers - 0R1F - Bristol-Myers Squibb Company
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on LSE.
Profile Summary - 0R1F - Bristol-Myers Squibb Company
About
Bristol-Myers Squibb Company is a global biopharmaceutical firm founded in 1887 that discovers, develops, licenses, manufactures, markets, distributes, and sells innovative medicines worldwide. Its portfolio addresses critical therapeutic areas including oncology, hematology, immunology, cardiovascular disease,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
